AU2001242084A1 - Polysaccharide-polypeptide conjugate - Google Patents

Polysaccharide-polypeptide conjugate

Info

Publication number
AU2001242084A1
AU2001242084A1 AU2001242084A AU4208401A AU2001242084A1 AU 2001242084 A1 AU2001242084 A1 AU 2001242084A1 AU 2001242084 A AU2001242084 A AU 2001242084A AU 4208401 A AU4208401 A AU 4208401A AU 2001242084 A1 AU2001242084 A1 AU 2001242084A1
Authority
AU
Australia
Prior art keywords
polysaccharide
polypeptide
polypeptide conjugate
amino group
free amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001242084A
Inventor
Helmut Eckert
Hans Loibner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Igeneon Krebs-Immuntherapie Forschungs- und Entwicklungs-GmbH
Original Assignee
Igeneon Krebs-Immuntherapie Forschungs- und Entwicklungs-GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Igeneon Krebs-Immuntherapie Forschungs- und Entwicklungs-GmbH filed Critical Igeneon Krebs-Immuntherapie Forschungs- und Entwicklungs-GmbH
Publication of AU2001242084A1 publication Critical patent/AU2001242084A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6851—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

The invention relates to a method for producing a polysaccharide-polypeptide conjugate by reacting a polysaccharide with a polypeptide comprising at least one free amino group. A polysaccharide carrier having vicinal hydroxy groups is oxidized onto the polypeptide whereby the ring is opened so as to create vicinal aldehyde groups and is reacted with one or more base-instable antigen polypeptide(s) containing at least one free amino group, the polypeptide(s) being bound directly to the polysaccharide carrier via at least one azomethine bond.
AU2001242084A 2000-03-21 2001-03-21 Polysaccharide-polypeptide conjugate Abandoned AU2001242084A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT4712000 2000-03-21
AT471/2000 2000-03-21
PCT/AT2001/000079 WO2001070272A1 (en) 2000-03-21 2001-03-21 Polysaccharide-polypeptide conjugate

Publications (1)

Publication Number Publication Date
AU2001242084A1 true AU2001242084A1 (en) 2001-10-03

Family

ID=3674758

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001242084A Abandoned AU2001242084A1 (en) 2000-03-21 2001-03-21 Polysaccharide-polypeptide conjugate

Country Status (10)

Country Link
EP (1) EP1267937B1 (en)
AT (1) ATE429251T1 (en)
AU (1) AU2001242084A1 (en)
CA (1) CA2404111C (en)
DE (1) DE50114852D1 (en)
DK (1) DK1267937T3 (en)
ES (1) ES2325528T3 (en)
MX (1) MXPA02008247A (en)
SI (1) SI1267937T1 (en)
WO (1) WO2001070272A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10209821A1 (en) 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Coupling of proteins to a modified polysaccharide
AT502293B1 (en) * 2002-05-15 2008-03-15 Igeneon Krebs Immuntherapie IMMUNOGENERAL, MONOCLONAL ANTIBODY
WO2005014655A2 (en) 2003-08-08 2005-02-17 Fresenius Kabi Deutschland Gmbh Conjugates of hydroxyalkyl starch and a protein
WO2005044861A1 (en) * 2003-10-31 2005-05-19 Wyeth Holdings Corporation Polysaccharides of helicobacter pylori
JP5396019B2 (en) * 2004-03-11 2014-01-22 フレゼニウス・カビ・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング Conjugates of hydroxyalkyl starch and protein
DE102006035899A1 (en) 2006-07-31 2008-02-07 Dade Behring Marburg Gmbh New polysaccharide-peptide-conjugate, where the peptide portion contains a sequence having a signal group that is splittable by thrombin at its carbon-terminal end, useful in a procedure for determining the thrombin generation in a sample

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU730694A1 (en) * 1976-07-05 1980-04-30 Всесоюзный Научно-Исследовательский Технологический Институт Антибиотиков И Ферментов Медицинского Назначения Terrilitine-modified dextran possessing fibrinolytic activity
WO1996020012A2 (en) * 1994-12-23 1996-07-04 Middlesex Sciences, Inc. Methods for preparing and purifying macromolecular conjugates
US6011008A (en) * 1997-01-08 2000-01-04 Yissum Research Developement Company Of The Hebrew University Of Jerusalem Conjugates of biologically active substances
CA2233725A1 (en) * 1998-03-31 1999-09-30 Hemosol Inc. Hemoglobin-hydroxyethyl starch complexes

Also Published As

Publication number Publication date
ES2325528T3 (en) 2009-09-08
WO2001070272A1 (en) 2001-09-27
DK1267937T3 (en) 2009-08-03
CA2404111C (en) 2010-05-25
SI1267937T1 (en) 2009-10-31
EP1267937A1 (en) 2003-01-02
MXPA02008247A (en) 2004-04-05
DE50114852D1 (en) 2009-06-04
ATE429251T1 (en) 2009-05-15
EP1267937B1 (en) 2009-04-22
CA2404111A1 (en) 2002-09-19

Similar Documents

Publication Publication Date Title
EP2345671B8 (en) Optimized fc variants and methods for their generation
WO2001070685A3 (en) Hydrazine-based and carbonyl-based bifunctional crosslinking reagents
DE50014571D1 (en) VEHICLE PHARMAKA CONJUGATES
ES547495A0 (en) PROCEDURE FOR THE PRODUCTION OF MONOCLONAL ANTIBODIES TO CYCLOSPORINS.
NZ590690A (en) Antibodies that bind to p-selectin glycoprotein ligand 1
HUP0402192A2 (en) Lyophilized preparation containing antibodies to the egf receptor
AU2910197A (en) Antibodies to the ed-b domain of fibronectin, their construction and uses
NZ337202A (en) Method for providing enhanced photosynthesis for horticultural crops by applying highly reflective particulate materials
MXPA04004814A (en) Methods for ligand discovery.
EP0870014A4 (en) Aldolase catalytic antibody
AU9742698A (en) Amino acid sequences for therapeutical and prophylactic applications to diseasesdue to (clostridium difficile) toxins
WO2000056901A3 (en) Linear and circular expression elements
RS50258B (en) Method for the preparation of citalopram
CA2348026A1 (en) Antibodies against semp1, methods for their production and uses thereof
EP2058334A3 (en) Monoclonal antibodies, cross-reactive antibodies and method for producing the same
AU2001242084A1 (en) Polysaccharide-polypeptide conjugate
AU3804195A (en) Process for the preparation of substituted 3-aminobnzonitriles
AU6078399A (en) Ligand presenting assembly (lpa), method of preparation and uses thereof
AU1278801A (en) Method for generating information related to the molecular structure of a biomolecule
AU5489498A (en) Non-aggregated fluorescent conjugates and method for obtaining them
IL160029A0 (en) Receptor, the use thereof, and mouse antibodies
AU2003232481A1 (en) Ferrocenyl ligands and method for the production of such ligands
AU5045493A (en) Process for preparing conjugates consisting of a specific binding partner and a carbohydrate-containing protein
AU2001250429A1 (en) Method for producing 2-alkyl-3-chlorophenols
WO2003016353A1 (en) Anti-ciguatoxin monoclonal antibody